TE

Thrive Earlier Detection

Acquired

Cambridge, United States · Founded 2019 · $367.0M raised

Employees
51–200
Founded
2019
Business Model
B2B
Total Funding
$367.0M
Last Round
$257.0M Series BJul 2020
Rounds
2
Acquisition Date
Jan 2021

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Thrive Earlier Detection was a Cambridge, Maryland-based liquid biopsy company commercializing CancerSEEK, a multi-cancer early detection blood test developed by Johns Hopkins researchers Bert Vogelstein, Ken Kinzler, and Nickolas Papadopoulos. Founded in 2019 with a $110M Series A, Thrive received FDA Breakthrough Device designation for detecting pancreatic and ovarian cancers. The company raised $257M in additional funding before being acquired by Exact Sciences in October 2020 for $2.15 billion.

Summary

Thrive Earlier Detection is a Biotech company based in Cambridge, United States, founded in 2019. It has raised $367.0M in total across 2 rounds, most recently a $257.0M Series B round in Jul 2020. Investors include Casdin Capital, Section 32 and Third Rock Ventures.

Funding & Exit History

AcquisitionAcquisition by Exact SciencesJan 2021

Sign up to see all 3 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
Avenzo

Avenzo is a San Diego, CA-based biopharma company to in-license and develop the next generation o...

San Diego, United States1–10Biotech, Oncology
Series BTotal funding$832.0MSep 2025
Bicycle TherapeuticsIPO

Novel bicyclic peptides and drug conjugates for cancer

Cambridge, United States201–500Biotech, Oncology
Private EquityTotal funding$607.0MJan 2024
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Thrive Earlier Detection on Indexed.vc
<a href="https://indexed.vc/companies/thrive-earlier-detection"><img src="https://indexed.vc/api/badge/company/thrive-earlier-detection" alt="Thrive Earlier Detection on Indexed.vc" width="260" height="76" /></a>